Lau Denys T, Nau David P
Pfizer Research Fellowship Program, Department of Health Management and Policy, The University of Michigan School of Public Policy, Ann Arbor, Michigan, USA.
Diabetes Care. 2004 Sep;27(9):2149-53. doi: 10.2337/diacare.27.9.2149.
This study examines the association between oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes.
Using administrative claims data (2000-2001) from a managed care organization in the Midwestern U.S., this study analyzed 900 enrollees, aged 18 years and over, with type 2 diabetes who were taking oral antihyperglycemic agents both years but who did not use insulin. Nonadherence was defined as a medication possession ratio (MPR) <80%. Multivariate logistic regression analyses were performed where hospitalization in 2001 was regressed on nonadherence to the oral antihyperglycemic drug regimen in 2000, while controlling for nonadherence to drugs for hypertension and dyslipidemia and for hospitalization in 2000, age, sex, intensity of the diabetes drug regimen, and comorbidities.
The proportion of enrollees who were nonadherent to the antihyperglycemic drug regimen in 2001 was 28.9%, whereas 18.8 and 26.9% were nonadherent to antihypertensive and lipid-modifying drugs, respectively. The increase in the hospitalization rate for 2001 was most apparent where the antihyperglycemic MPR for 2000 dropped to <80%. Enrollees who were nonadherent to oral diabetes medications in 2000 were at higher risk of hospitalization in 2001 (odds ratio 2.53; 95% CI 1.38-4.64), whereas nonadherence to drugs for hypertension and dyslipidemia were not significantly associated with hospitalization.
Patients with type 2 diabetes who do not obtain at least 80% of their oral antihyperglycemic medications across 1 year are at a higher risk of hospitalization in the following year.
本研究探讨2型糖尿病患者口服降糖药物治疗依从性不佳与随后住院之间的关联。
利用美国中西部一家管理式医疗组织的管理索赔数据(2000 - 2001年),本研究分析了900名年龄在18岁及以上的2型糖尿病参保者,他们在这两年均服用口服降糖药但未使用胰岛素。治疗依从性不佳定义为药物持有率(MPR)<80%。进行多因素逻辑回归分析,以2001年的住院情况为因变量,以2000年口服降糖药物治疗方案的依从性不佳为自变量,同时控制高血压和血脂异常药物的依从性不佳情况、2000年的住院情况、年龄、性别、糖尿病药物治疗方案的强度以及合并症。
2001年降糖药物治疗方案依从性不佳的参保者比例为28.9%,而降压药和调脂药的依从性不佳比例分别为18.8%和26.9%。2001年住院率的增加在2000年降糖MPR降至<80%的人群中最为明显。2000年口服糖尿病药物治疗依从性不佳的参保者在2001年住院风险更高(比值比2.53;95%可信区间1.38 - 4.64),而高血压和血脂异常药物的依从性不佳与住院无显著关联。
2型糖尿病患者在1年中口服降糖药物获取量未达到至少80%,次年住院风险更高。